BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 29214433)

  • 1. Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.
    Qin H; Wang R; Wei G; Wang H; Pan G; Hu R; Wei Y; Tang R; Wang J
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):525-534. PubMed ID: 29214433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
    Cao Q; Zhang J; Zhang T
    Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease.
    Wang HH; Wang XW; Tang CE
    J Cancer Res Ther; 2011; 7(2):138-42. PubMed ID: 21768699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.
    Hou X; Wu X; Huang P; Zhan J; Zhou T; Ma Y; Qin T; Luo R; Feng Y; Xu Y; Chen L; Zhang L
    Int J Cancer; 2015 Oct; 137(7):1672-8. PubMed ID: 25824984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin regulates growth and migration of human nasopharyngeal cancer cells.
    Yang G; Zhang Y; Wu J; Xiong J; Deng H; Wang J; Yang C; Zhu Z
    Mol Med Rep; 2011; 4(6):1169-73. PubMed ID: 21785824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF; Zhou DN; Pan ZY; Yin P
    Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis.
    Tu Z; Chen Q; Zhang JT; Jiang X; Xia Y; Chan HC
    Oncotarget; 2016 Nov; 7(47):76955-76965. PubMed ID: 27769067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
    Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
    Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
    BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis.
    Liu TH; Zheng F; Cai MY; Guo L; Lin HX; Chen JW; Liao YJ; Kung HF; Zeng YX; Xie D
    Oncotarget; 2016 May; 7(18):25836-48. PubMed ID: 27028992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.
    Xu L; Fan S; Zhao J; Zhou P; Chu S; Luo J; Wen Q; Chen L; Wen S; Wang L; Shi L
    Diagn Pathol; 2017 Jan; 12(1):2. PubMed ID: 28061788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
    Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
    J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
    BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAI1 overexpression promotes apoptosis and inhibits proliferation, cell cycle, migration, and invasion in nasopharyngeal carcinoma cells.
    Guo Z; Wang Y; Yang J; Zhong J; Liu X; Xu M
    Am J Otolaryngol; 2017; 38(5):511-517. PubMed ID: 28583320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
    Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
    Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of epidermal growth factor receptor and type 1 insulin-like growth factor receptor in nasopharyngeal carcinoma.
    Yuan Y; Zhou X; Song J; Qiu X; Li J; Ye L; Meng X; Xia D
    Ann Otol Rhinol Laryngol; 2008 Mar; 117(3):192-200. PubMed ID: 18444479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
    Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
    Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.
    Zheng J; Li J; Xu L; Xie G; Wen Q; Luo J; Li D; Huang D; Fan S
    PLoS One; 2014; 9(2):e89220. PubMed ID: 24551240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of flotillin-1 promotes invasion and metastasis by activating TGF-β signaling in nasopharyngeal carcinoma.
    Cao S; Cui Y; Xiao H; Mai M; Wang C; Xie S; Yang J; Wu S; Li J; Song L; Guo X; Lin C
    Oncotarget; 2016 Jan; 7(4):4252-64. PubMed ID: 26646322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.